Hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session on how can we best use our limited resources and at the same time insure safe and effective drugs to diseases which occur infrequently, June 26, 1980
United States.Congress.House.Committee on Interstate and Foreign Commerce.Subcommittee on Health and the Environment.
Washington U.S.G.P.O.
1980
At head of title: Volume II : drug regulation reform : oversight : orphan drugs
Drugs